Reply to : "Is baseline MASH fibrosis the key determinant for survival after bariatric surgery ?"

G Lassailly1, F Pattou2, P Mathurin3

  • 1Service des Maladies de l'Appareil Digestif et de la Nutrition, Centre Hospitalier Universitaire de Lille, Lille, France; European Genomic Institute for Diabetes, UMR 1190 Translational Research for Diabetes, Inserm, CHU Lille, University of Lille, Lille, France.

Abstract

No abstract available in PubMed .

Related Concept Videos